The development of effective vaccines to combat infectious diseases is a complex multi-year
and multi-stakeholder process. To accelerate the development of vaccines for coronavirus …

As one of the major therapeutic options for cancer treatment, chemotherapy has limited
selectivity against cancer cells. Consequently, this therapeutic strategy offers a small …

The persistent coronavirus disease 2019 (COVID-19), characterized by severe respiratory
syndrome, is caused by coronavirus 2 (SARS-CoV-2), and it poses a major threat to public …

Since the beginning of 2020, the world has been in a race to develop vaccines that can
control the COVID-19 pandemic. More than 250 projects have been initiated for this …

Today the coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus-2 (SARS-CoV-2), has become a global health problem. After more …

The ongoing coronavirus disease 2019 (COVID‐19) pandemic, caused by severe acute
respiratory coronavirus 2 (SARS‐CoV‐2), has killed untold millions worldwide and has …

The progress in the development of various vaccine platforms against SARS-CoV-2 have
been rather remarkable owing to advancement in molecular and biologic sciences. Most of …

The importance of Streptococcus pneumoniae has been well established. These bacteria
can colonize infants and adults without symptoms, but in some cases can spread, invade …

Messenger ribonucleic acid (mRNA) vaccines made their successful public debut in the
effort against the COVID‐19 outbreak starting in late 2019, although the history of mRNA …

Since the outbreak of the novel coronavirus disease 2019 (COVID-19) in Wuhan, China,
many health care systems have been heavily engaged in treating and preventing the …